OBJECTIVE: Incidence and mortality from ischaemic heart disease (IHD) was studied in an extended cohort of 22,377 workers first employed at the Mayak Production Association during 1948-82 and followed up to the end of 2008. METHODS: Relative risks and excess relative risks per unit dose (ERR/Gy) were calculated based on the maximum likelihood using Epicure software (Hirosoft International Corporation, Seattle, WA). Dose estimates used in analyses were provided by an updated "Mayak Worker Dosimetry System-2008". RESULTS: A significant increasing linear trend in IHD incidence with total dose from external γ-rays was observed after having adjusted for non-radiation factors and dose from internal radiation {ERR/Gy = 0.10 [95% confidence interval (CI): 0.04 to 0.17]}. The pure quadratic model provided a better fit of the data than did the linear one. No significant association of IHD mortality with total dose from external γ-rays after having adjusted for non-radiation factors and dose from internal alpha radiation was observed in the study cohort [ERR/Gy = 0.06 (95% CI: <0 to 0.15)]. A significant increasing linear trend was observed in IHD mortality with total absorbed dose from internal alpha radiation to the liver after having adjusted for non-radiation factors and dose from external γ-rays in both the whole cohort [ERR/Gy = 0.21 (95% CI: 0.01 to 0.58)] and the subcohort of workers exposed at alpha dose <1.00 Gy [ERR/Gy = 1.08 (95% CI: 0.34 to 2.15)]. No association of IHD incidence with total dose from internal alpha radiation to the liver was found in the whole cohort after having adjusted for non-radiation factors and external gamma dose [ERR/Gy = 0.02 (95% CI: not available to 0.10)]. Statistically significant dose effect was revealed in the subcohort of workers exposed to internal alpha radiation at dose to the liver <1.00 Gy [ERR/Gy = 0.44 (95% CI: 0.09 to 0.85)]. CONCLUSION: This study provides strong evidence of IHD incidence and mortality association with external γ-ray exposure and some evidence of IHD incidence and mortality association with internal alpha-radiation exposure. ADVANCES IN KNOWLEDGE: It is the first time the validity of internal radiation dose estimates has been shown to affect the risk of IHD incidence.
OBJECTIVE: Incidence and mortality from ischaemic heart disease (IHD) was studied in an extended cohort of 22,377 workers first employed at the Mayak Production Association during 1948-82 and followed up to the end of 2008. METHODS: Relative risks and excess relative risks per unit dose (ERR/Gy) were calculated based on the maximum likelihood using Epicure software (Hirosoft International Corporation, Seattle, WA). Dose estimates used in analyses were provided by an updated "Mayak Worker Dosimetry System-2008". RESULTS: A significant increasing linear trend in IHD incidence with total dose from external γ-rays was observed after having adjusted for non-radiation factors and dose from internal radiation {ERR/Gy = 0.10 [95% confidence interval (CI): 0.04 to 0.17]}. The pure quadratic model provided a better fit of the data than did the linear one. No significant association of IHD mortality with total dose from external γ-rays after having adjusted for non-radiation factors and dose from internal alpha radiation was observed in the study cohort [ERR/Gy = 0.06 (95% CI: <0 to 0.15)]. A significant increasing linear trend was observed in IHD mortality with total absorbed dose from internal alpha radiation to the liver after having adjusted for non-radiation factors and dose from external γ-rays in both the whole cohort [ERR/Gy = 0.21 (95% CI: 0.01 to 0.58)] and the subcohort of workers exposed at alpha dose <1.00 Gy [ERR/Gy = 1.08 (95% CI: 0.34 to 2.15)]. No association of IHD incidence with total dose from internal alpha radiation to the liver was found in the whole cohort after having adjusted for non-radiation factors and external gamma dose [ERR/Gy = 0.02 (95% CI: not available to 0.10)]. Statistically significant dose effect was revealed in the subcohort of workers exposed to internal alpha radiation at dose to the liver <1.00 Gy [ERR/Gy = 0.44 (95% CI: 0.09 to 0.85)]. CONCLUSION: This study provides strong evidence of IHD incidence and mortality association with external γ-ray exposure and some evidence of IHD incidence and mortality association with internal alpha-radiation exposure. ADVANCES IN KNOWLEDGE: It is the first time the validity of internal radiation dose estimates has been shown to affect the risk of IHD incidence.
Authors: Maria B Moseeva; Tamara V Azizova; Evgenia S Grigoryeva; Richard Haylock Journal: Radiat Environ Biophys Date: 2014-01-31 Impact factor: 1.925
Authors: H G Claycamp; N D Okladnikova; T V Azizova; Z D Belyaeva; B B Boecker; V S Pesternikova; B R Scott; S Shekhter-Levin; M V Sumina; N B Sussman; I I Teplyakov; N Wald Journal: Health Phys Date: 2000-07 Impact factor: 1.316
Authors: T V Azizova; G V Zhuntova; R G E Haylock; M B Moseeva; E S Grigoryeva; N Hunter; M V Bannikova; Z D Belyaeva; E Bragin Journal: Radiat Res Date: 2013-11-12 Impact factor: 2.841
Authors: N A Koshurnikova; L A Buldakov; G D Bysogolov; M G Bolotnikova; N S Komleva; V S Peternikova Journal: Sci Total Environ Date: 1994-03-01 Impact factor: 7.963
Authors: N S Shilnikova; D L Preston; E Ron; E S Gilbert; E K Vassilenko; S A Romanov; I S Kuznetsova; M E Sokolnikov; P V Okatenko; V V Kreslov; N A Koshurnikova Journal: Radiat Res Date: 2003-06 Impact factor: 2.841
Authors: Cristoforo Simonetto; Tamara V Azizova; Evgenia S Grigoryeva; Jan C Kaiser; Helmut Schöllnberger; Markus Eidemüller Journal: PLoS One Date: 2014-05-14 Impact factor: 3.240
Authors: Tamara V Azizova; Maria V Bannikova; Evgenia S Grigorieva; Yaroslava P Bagaeva; Elena V Azizova Journal: Radiat Environ Biophys Date: 2016-03-19 Impact factor: 1.925
Authors: Michael Gillies; David B Richardson; Elisabeth Cardis; Robert D Daniels; Jacqueline A O'Hagan; Richard Haylock; Dominique Laurier; Klervi Leuraud; Monika Moissonnier; Mary K Schubauer-Berigan; Isabelle Thierry-Chef; Ausrele Kesminiene Journal: Radiat Res Date: 2017-07-10 Impact factor: 2.841
Authors: Helmut Schöllnberger; Jan Christian Kaiser; Markus Eidemüller; Lydia B Zablotska Journal: Radiat Environ Biophys Date: 2019-11-28 Impact factor: 1.925
Authors: Bjorn Baselet; Charlotte Rombouts; Abderrafi Mohammed Benotmane; Sarah Baatout; An Aerts Journal: Int J Mol Med Date: 2016-10-17 Impact factor: 4.101
Authors: Lydia B Zablotska; Nora Fenske; Maria Schnelzer; Sergey Zhivin; Dominique Laurier; Michaela Kreuzer Journal: Int Arch Occup Environ Health Date: 2017-09-22 Impact factor: 3.015
Authors: Omid Azimzadeh; Tamara Azizova; Juliane Merl-Pham; Vikram Subramanian; Mayur V Bakshi; Maria Moseeva; Olga Zubkova; Stefanie M Hauck; Nataša Anastasov; Michael J Atkinson; Soile Tapio Journal: Oncotarget Date: 2017-02-07
Authors: Jeri L Anderson; Stephen J Bertke; James Yiin; Kaitlin Kelly-Reif; Robert Douglas Daniels Journal: Occup Environ Med Date: 2020-09-03 Impact factor: 4.402